Announce Date | 07/24/2025 |
EPS Normalized Actual | $2.75 (Beat by $0.09) |
EPS GAAP Actual | $2.75 (Beat by $0.09) |
Revenue Actual | $0B |
Revenue Surprise | Beat by $0M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $2.54001 |
EPS GAAP Estimate | $2.54001 |
Revenue Estimate | $9.814631912B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 13.5 | 16.4 | 13.21126 | 13.88932 | 2 |
Dec 2027 | 12.99667 | 17.03 | 12.81458 | 13.18799 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 2.46 | -0.23036 | 0B | -INF% | -10088.78M |
FQ1 2025 (Mar 2025) | 2.24 | -0.14504 | 9.822B | 7.3% | 281.11M |
FQ4 2024 (Dec 2024) | 1.98 | 1.98 | 10.088B | 6.42% | 10088M |
FQ3 2024 (Sep 2024) | 2.17 | 2.17 | 9.731B | 5.33% | 9731M |
FQ2 2024 (Jun 2024) | 2.37 | 2.37 | 9.575B | 100% | 9575M |
FQ1 2024 (Mar 2024) | 2.24 | 2.24 | 9.105B | 2.65% | 9105M |
FQ4 2023 (Dec 2023) | 1.92 | 1.92 | 9.44B | -66.76% | 9440M |
FQ3 2023 (Sep 2023) | 2.29 | 2.29 | 9.212B | -68.68% | 9212M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
2.54001
Consensus Revenue Estimates
9.814631912B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.29236 | -- | 3.23947 | 3.35939 | 7 |
FQ3 2027 (Sep 2027) | 3.10781 | -- | 3.06361 | 3.14995 | 4 |
FQ2 2027 (Jun 2027) | 3.1056 | -- | 3.06143 | 3.14771 | 3 |
FQ1 2027 (Mar 2027) | 2.77953 | -- | 2.71658 | 2.83419 | 4 |
FQ4 2026 (Dec 2026) | 3.3155 | -- | 3.3155 | 3.3155 | 8 |
FQ3 2026 (Sep 2026) | 3.0008 | -- | 3.0008 | 3.0008 | 8 |
FQ2 2026 (Jun 2026) | 2.9552 | 16.76 | 2.9552 | 2.9552 | 8 |
FQ1 2026 (Mar 2026) | 2.7171 | 17.56 | 2.7171 | 2.7171 | 8 |
FQ4 2025 (Oct 2025) | 2.69757 | 26.6 | 2.63031 | 2.7835 | 5 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 11.9B | -- | 11.75B | 12.09B | 6 |
FQ3 2027 (Sep 2027) | 11.12B | -- | 11B | 11.24B | 2 |
FQ2 2027 (Jun 2027) | 11.08B | -- | 10.96B | 11.2B | 2 |
FQ1 2027 (Mar 2027) | 10.41B | -- | 10.23B | 10.57B | 4 |
FQ4 2026 (Dec 2026) | 9.62B | -- | 9.62B | 9.62B | 10 |
FQ3 2026 (Sep 2026) | 9.61B | -- | 9.61B | 9.61B | 7 |
FQ2 2026 (Jun 2026) | 9.61B | -- | 9.61B | 9.61B | 5 |
FQ1 2026 (Mar 2026) | 9.61B | -2.25 | 9.61B | 9.61B | 5 |
FQ4 2025 (Oct 2025) | 10.17B | 0.76 | 9.97B | 10.41B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 2.69036 | 2.46 | -0.23036 | -9.36% |
FQ1 2025 (Mar 2025) | 2.38504 | 2.24 | -0.14504 | -6.47% |
FQ4 2024 (Dec 2024) | 1.98 | 1.98 | 100% | |
FQ3 2024 (Sep 2024) | 2.17 | 2.17 | 100% | |
FQ2 2024 (Jun 2024) | 2.37 | 2.37 | 100% | |
FQ1 2024 (Mar 2024) | 2.24 | 2.24 | 100% | |
FQ4 2023 (Dec 2023) | 1.92 | 1.92 | 100% | |
FQ3 2023 (Sep 2023) | 2.29 | 2.29 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $10.09B | $0B | $-10088.78M | -INF% |
FQ1 2025 (Mar 2025) | $9.54B | $9.82B | $281.11M | 2.86% |
FQ4 2024 (Dec 2024) | $0B | $10.09B | $10088M | 100% |
FQ3 2024 (Sep 2024) | $0B | $9.73B | $9731M | 100% |
FQ2 2024 (Jun 2024) | $0B | $9.58B | $9575M | 100% |
FQ1 2024 (Mar 2024) | $0B | $9.11B | $9105M | 100% |
FQ4 2023 (Dec 2023) | $0B | $9.44B | $9440M | 100% |
FQ3 2023 (Sep 2023) | $0B | $9.21B | $9212M | 100% |